Hrt Financial LP Applied Therapeutics Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.25 - $7.4 $222,477 - $731,704	98,879 New	98,879 $672,000
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.77 $14,933 - $32,830	11,852 New	11,852 $29,000
Q3 2022 Nov 14, 2022	SELL	$0.86 - $1.55 $99,679 - $179,654	-115,906 Reduced 80.33%	28,380 $26,000
Q2 2022 Aug 12, 2022	BUY	$0.76 - $2.64 $72,617 - $252,249	95,549 Added 196.05%	144,286 $136,000
Q1 2022 May 16, 2022	BUY	$1.48 - $6.22 $72,130 - $303,144	48,737 New	48,737 $102,000

100

103M

797K

80.8K

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $397M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.